Directed share issue of 60 million SEK to finance Iconovo’s new inhalation platform

A few weeks ago, Lund-based Iconovo gave a sign of their growing confidence when they announced the biggest investment in the company’s history in the form of a new inhalation platform.

Yesterday, a directed share issued to a number of heavy institutional investors, raising 60 million SEK prior to costs, made it clear that the new project will be off to a solid financial start. Read more